Metraipolis › archive › dc_17b10e4da558

Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? — Europe PMC PMID:41147362

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41147362
DOI
10.1177/02698811251375104
License (as archived)
solo-consultazione
Archived
2026-11-09T00:37:30.070Z
SHA-256 of the archived text
8de886a7fdfede945be50c3a3471eb83e4c641d1e09581c710e4061bdedfe054
Stable URL of this page
https://metraipolis.com/documento/dc_17b10e4da558

How to cite

Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? — Europe PMC PMID:41147362 — Europe PMC (en), https://europepmc.org/article/MED/41147362 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17b10e4da558 (Metraipolis archive dc_17b10e4da558, sha256 8de886a7fdfede945be50c3a3471eb83e4c641d1e09581c710e4061bdedfe054)
BibTeX
@misc{dc17b10e4da558,
  title = {Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? — Europe PMC PMID:41147362},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41147362},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17b10e4da558; sha256 8de886a7fdfede945be50c3a3471eb83e4c641d1e09581c710e4061bdedfe054},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41147362. Agents can read the archived copy with the MCP tool read_document.